Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care.
Jesenak M, Bobcakova DA, Djukanovic R, Gaga M, Hanania NA, Heaney LG, Pavord I, Quirce S, Ryan DD, Fokkens W, Conti DD, Hellings PW, Scadding G, Van Staeyen E, Bjermer LH, Diamant Z. Jesenak M, et al. Among authors: hanania na. Chest. 2024 Dec 11:S0012-3692(24)05617-4. doi: 10.1016/j.chest.2024.11.035. Online ahead of print. Chest. 2024. PMID: 39672229 Free article. Review.
The emerging role of alarmin-targeting biologics in the treatment of patients with COPD.
Celli BR, Anzueto A, Singh D, Hanania NA, Fabbri L, Martinez FJ, Soler X, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y, Radwan A. Celli BR, et al. Among authors: hanania na. Chest. 2024 Dec 2:S0012-3692(24)05602-2. doi: 10.1016/j.chest.2024.09.049. Online ahead of print. Chest. 2024. PMID: 39631681 Free article. Review.
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM. Bhatt SP, et al. Among authors: hanania na. Respir Med. 2024 Oct 30;236:107846. doi: 10.1016/j.rmed.2024.107846. Online ahead of print. Respir Med. 2024. PMID: 39481660 Free article.
Dynamic and prognostic proteomic associations with FEV1 decline in chronic obstructive pulmonary disease.
Ruvuna L, Hijazi K, Guzman DE, Guo C, Loureiro J, Khokhlovich E, Morris M, Obeidat M, Pratte KA, DiLillo KM, Sharma S, Kechris K, Anzueto A, Barjaktarevic I, Bleecker ER, Casaburi R, Comellas A, Cooper CB, DeMeo DL, Foreman M, Flenaugh EL, Han MK, Hanania NA, Hersh CP, Krishnan JA, Labaki WW, Martinez FJ, O'Neal WK, Paine R 3rd, Peters SP, Woodruff PG, Wells JM, Wendt CH, Arnold KB, Barr RG, Curtis JL, Ngo D, Bowler RP; SPIROMICS, COPDGene and MESA-Lung Investigators. Ruvuna L, et al. Among authors: hanania na. medRxiv [Preprint]. 2024 Aug 8:2024.08.07.24311507. doi: 10.1101/2024.08.07.24311507. medRxiv. 2024. PMID: 39148837 Free PMC article. Preprint.
332 results